The Pathological Activation of Microglia Is Modulated by Sexually Dimorphic Pathways

Int J Mol Sci. 2023 Mar 1;24(5):4739. doi: 10.3390/ijms24054739.

Abstract

Microglia are the primary immunocompetent cells of the central nervous system (CNS). Their ability to survey, assess and respond to perturbations in their local environment is critical in their role of maintaining CNS homeostasis in health and disease. Microglia also have the capability of functioning in a heterogeneous manner depending on the nature of their local cues, as they can become activated on a spectrum from pro-inflammatory neurotoxic responses to anti-inflammatory protective responses. This review seeks to define the developmental and environmental cues that support microglial polarization towards these phenotypes, as well as discuss sexually dimorphic factors that can influence this process. Further, we describe a variety of CNS disorders including autoimmune disease, infection, and cancer that demonstrate disparities in disease severity or diagnosis rates between males and females, and posit that microglial sexual dimorphism underlies these differences. Understanding the mechanism behind differential CNS disease outcomes between men and women is crucial in the development of more effective targeted therapies.

Keywords: autoimmunity; glioblastoma; infection; inflammation; microglia; sexual dimorphism.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases* / metabolism
  • Central Nervous System / pathology
  • Central Nervous System Diseases* / metabolism
  • Female
  • Humans
  • Male
  • Microglia / metabolism
  • Phenotype

Grants and funding

This research received no external funding.